White Plains, NY, United States of America

Alan Berezov


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan Berezov: Innovator in Cholesterol Treatment

Introduction

Alan Berezov is a notable inventor based in White Plains, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of elevated plasma cholesterol. His innovative work has the potential to impact many lives by addressing cholesterol-related health issues.

Latest Patents

Alan Berezov holds a patent for "Methods of treating elevated plasma cholesterol." This invention relates to compounds that are encompassed by specific formulas and pharmaceutically acceptable salts, solvates, or compositions thereof. The compounds are small molecules that interact with PCSK9, modulating its activity to significantly increase low-density lipoprotein receptor expression and activity. This innovation aims to lower total circulating cholesterol and is useful for treating and delaying the onset of diseases associated with elevated cholesterol.

Career Highlights

Throughout his career, Alan has worked with reputable organizations, including the Institut De Cardiologie De Montreal and Affina Biotechnologies, Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas in the medical field.

Collaborations

Alan has collaborated with notable professionals in his field, including Alexander Vinitsky and Steve Poirier. These partnerships have contributed to the advancement of his research and the successful development of his patent.

Conclusion

Alan Berezov's contributions to the treatment of elevated plasma cholesterol highlight his role as an innovator in the medical field. His patent and collaborations reflect his commitment to improving health outcomes for individuals affected by cholesterol-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…